President Trump Holds News Conference In Brady Press Briefing Room
Celebrity Pictures > Archives > 2020 > August >
President Trump Holds News Conference In Brady Press Briefing Room (33 pictures)
View All Images- United States President Donald J. Trump, second left, speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. At center is Stephen Hahn, Commissioner, US Food and Drug Administration (FDA) and at right is US Secretary of Health and Human Services (HHS) Alex Azar. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump walks to the podium during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. At center left is Stephen Hahn, Commissioner, US Food and Drug Administration (FDA) and at right is US Secretary of Health and Human Services (HHS) Alex Azar Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump, left, arrives to a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Also pictured are US Secretary of Health and Human Services (HHS) Alex Azar, center, and Stephen Hahn, Commissioner, US Food and Drug Administration (FDA). Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump, second left, speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. At center is Stephen Hahn, Commissioner, US Food and Drug Administration (FDA) and at right is US Secretary of Health and Human Services (HHS) Alex Azar. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump, center, speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. US Secretary of Health and Human Services (HHS) Alex Azar looks on from right and Stephen Hahn, Commissioner, US Food and Drug Administration (FDA) looks on from center left. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump, left, speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. At center is US Secretary of Health and Human Services (HHS) Alex Azar and at right is Stephen Hahn, Commissioner, US Food and Drug Administration (FDA). Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States Secretary of Health and Human Services (HHS) Alex Azar, right, listens as US President Donald J. Trump speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump, Stephen Hahn, Commissioner, US Food and Drug Administration (FDA), and US Secretary of Health and Human Services (HHS) Alex Azar, depart a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States Secretary of Health and Human Services (HHS) Alex Azar, center, speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. At center left is US President Donald J. Trump and at right is Stephen Hahn, Commissioner, US Food and Drug Administration (FDA). Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States Representative Jim Jordan (Republican of Ohio), center, listens as US President Donald J. Trump speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump arrives to a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has been issued an emergency use authorization from the FDA. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has been issued an emergency use authorization from the FDA. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump arrives to a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has been issued an emergency use authorization from the FDA. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States Secretary of Health and Human Services (HHS) Alex Azar, arrives to a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump, left, speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. At right is Stephen Hahn, Commissioner, United States Food and Drug Administration (FDA). Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has been issued an emergency use authorization from the FDA. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. US Secretary of Health and Human Services (HHS) Alex Azar looks on from right. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump listens during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- Stephen Hahn, Commissioner, United States Food and Drug Administration (FDA), left, and United States Secretary of Health and Human Services (HHS) Alex Azar, arrive to a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States Secretary of Health and Human Services (HHS) Alex Azar, speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- Scott Atlas, senior fellow at Stanford University's Hoover Institution, left, and United States Representative Jim Jordan (Republican of Ohio), listen as US President Donald J. Trump speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States Secretary of Health and Human Services (HHS) Alex Azar, center, speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. US President Donald J. Trump looks on from left and Stephen Hahn, Commissioner, US Food and Drug Administration (FDA) looks on from right. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump listens during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump listens during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- Stephen Hahn, Commissioner, United States Food and Drug Administration (FDA), center, speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Looking on from left is US President Donald J. Trump and from right is US Secretary of Health and Human Services (HHS) Alex Azar. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- Scott Atlas, senior fellow at Stanford University's Hoover Institution, left and United States Representative Jim Jordan (Republican of Ohio), left center, listen as US President Donald J. Trump speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- Stephen Hahn, Commissioner, United States Food and Drug Administration (FDA) speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump, right, departs a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump, Stephen Hahn, Commissioner, US Food and Drug Administration (FDA), US Secretary of Health and Human Services (HHS) Alex Azar, and US Representative Jim Jordan (Republican of Ohio) depart a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump listens during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. US Secretary of Health and Human Services (HHS) Alex Azar looks on from left. Credit: Stefani Reynolds / Pool via CNP/AdMedia
- United States President Donald J. Trump speaks during a news conference in the James S. Brady Press Briefing Room at the White House in Washington D.C., U.S., on Sunday, August 23, 2020. Trump announced that a new treatment for COVID-19, which uses blood plasma donated by people who have recovered from the disease, has received an emergency use authorization from U.S. regulators. US Secretary of Health and Human Services (HHS) Alex Azar looks on from center. Credit: Stefani Reynolds / Pool via CNP/AdMedia `